JPRN-jRCT2031210011进行中（未招募）2 期
A phase II study to evaluate the efficacy and safety of M605106 short contact therapy in patients with acne vulgaris
ishiura Tomoyuki0 个研究点目标入组 240 人开始时间: 2021年4月5日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 12age old 至 <= 49age old（—）
- 性别
- All
入选标准
- •Patients with Acne vulgaris 12 to 49 years old
排除标准
- •- Patients with concurrent presense of serious cardiac, hepatic, renal, plumonary, hematologic, or other diseases considered inappropriate for paticipation in the clinical study
- •- Patients with a history of hypersensitivity to investigational drug ingredients
- •- Pregnant or lactating women
研究者
相似试验
招募中
2 期
A Phase II stUdy to evaluate the efficacy and safety of deep-inspiration breath-hold Daily aDaptive radiotherapy In ceNtrally located lunG tumorsLung cancerPrimary lung tumorMetastatic lung tumorPulmonary metastasisOligometastasisD008175JPRN-jRCT1052230085Takashi Mizowaki25
进行中（未招募）
1 期
Evaluation of efficacy and safety of MEDI2070 in patients with active, moderate-to-severe Crohn's disease.MedDRA version: 19.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's DiseaseEUCTR2012-004098-26-DEAstraZeneca AB120
进行中（未招募）
1 期
Evaluation of efficacy and safety of MEDI2070 in patients with active, moderate-to-severe Crohn's disease.MedDRA version: 14.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's DiseaseEUCTR2012-004098-26-CZAstraZeneca AB120
进行中（未招募）
1 期
Evaluation of efficacy and safety of MEDI2070 in patients with active, moderate-to-severe Crohn's disease.MedDRA version: 18.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's DiseaseEUCTR2012-004098-26-FRAstraZeneca AB121
进行中（未招募）
1 期
Evaluation of efficacy and safety of MEDI2070 in patients with active,moderate-to-severe Crohn's disease.Crohn's DiseaseEUCTR2012-004098-26-ITASTRAZENECA120